| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |